Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/07/020214
CTRI/2019/07/020214
Not yet recruiting
Phase 2

CLINICAL EVALUATION OF CHITRAKA HARITAKI AND LAVANGADI VATI IN THE MANAGEMENT OF KAPHAJA KASA (STABLE CHRONIC BRONCHITIS)

Central Council for Research in Ayurvedic Sciences0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Central Council for Research in Ayurvedic Sciences
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients of either sex aged between 18 to 65 years.
  • •2\.Patients suffering from Stable Chronic Bronchitis. (Chronic Bronchitis is defined as a cough that occurs every day with sputum production that lasts for at least three months, two years in a row).
  • •3\.Patients having FEV1 \> 80%.
  • •4\.Patient willing and able to participate in the study for 16 weeks.

Exclusion Criteria

  • •1\.Any other pulmonary diagnosis like Emphysema, Cor pulmonale, Cyanosis, Pneumonia, Asthma, Cystic fibrosis, Tuberculosis, Lung cancer etc.
  • •2\.Patients with uncontrolled Diabetes Mellitus (Blood Sugar Fasting \> 250 mg/dl)
  • •3\.Patients with poorly controlled Hypertension ( \>\=160 / 100 mmHg).
  • •4\.Patients on prolonged ( \> 6 weeks) medication with corticosteroids, bronchodilators, Mast cell stabilizers, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study.
  • •5\.Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho\-Neuro\-Endocrinal disorders etc).
  • •6\.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
  • •7\.Symptomatic patients with clinical evidence of Heart failure.
  • •8\.Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) \> 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine \>1\.2mg/dL).
  • •9\.Alcoholics and/or drug abusers.
  • •10\.Patients who have completed participation in any other clinical trial during the past six months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Management of Dushta Pratishyaya w.s.r. to chronic sinusitis
CTRI/2017/03/008225Institute for Post Graduation Teaching And Research in Ayurveda119
Active, not recruiting
Phase 3
A clinical study on Bronchial Asthma in childre
CTRI/2016/05/006971Director IPGT RA GAU JAMNAGAR30
Not yet recruiting
Not Applicable
A comparative clinical study of four different variety of Teekshana Apamarga Pratisaraneeya Kshara in the management of Abhyantara Arsha with special reference to internal Haemorrhoids
CTRI/2020/08/027123ational Institute of Ayurveda
Not yet recruiting
Phase 2
A clinical study on Amavata wsrt Rheumatoid Arthritis.
CTRI/2018/06/014679Government Ayurved college Nagpur
Not yet recruiting
Phase 2
Role of khadirastak kwatha and manjisthadi taila(external application) in treatment of psoriasisHealth Condition 1: L409- Psoriasis, unspecified
CTRI/2024/04/065046J S Ayurved Mahavidhyalay